Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia.

Bartos C, Ambrus R, Katona G, Sovány T, Gáspár R, Márki Á, Ducza E, Ivanov A, Tömösi F, Janáky T, Szabó-Révész P.

Drug Des Devel Ther. 2019 Nov 28;13:4007-4020. doi: 10.2147/DDDT.S220876. eCollection 2019.

2.

Spray Drying of a Subcritical Extract Using Marrubium vulgare as a Method of Choice for Obtaining High Quality Powder.

Gavarić A, Vladić J, Ambrus R, Jokić S, Szabó-Révész P, Tomić M, Blažić M, Vidović S.

Pharmaceutics. 2019 Oct 11;11(10). pii: E523. doi: 10.3390/pharmaceutics11100523.

3.

Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.

Alshweiat A, Ambrus R, Csoka I.

Curr Med Chem. 2019;26(35):6459-6492. doi: 10.2174/0929867326666190827151741. Review.

PMID:
31453778
4.

3D-printed electrospinning setup for the preparation of loratadine nanofibers with enhanced physicochemical properties.

Ambrus R, Alshweiat A, Csóka I, Ovari G, Esmail A, Radacsi N.

Int J Pharm. 2019 Aug 15;567:118455. doi: 10.1016/j.ijpharm.2019.118455. Epub 2019 Jun 21.

PMID:
31233846
5.

Stability test of novel combined formulated dry powder inhalation system containing antibiotic: physical characterization and in vitro-in silico lung deposition results.

Benke E, Farkas Á, Balásházy I, Szabó-Révész P, Ambrus R.

Drug Dev Ind Pharm. 2019 Aug;45(8):1369-1378. doi: 10.1080/03639045.2019.1620268. Epub 2019 Jun 4.

PMID:
31096805
6.

Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery.

Ismail R, Sovány T, Gácsi A, Ambrus R, Katona G, Imre N, Csóka I.

Pharm Res. 2019 May 13;36(7):99. doi: 10.1007/s11095-019-2620-9.

7.

Interaction Studies Between Levodopa and Different Excipients to Develop Coground Binary Mixtures for Intranasal Application.

Kiss T, Alapi T, Varga G, Bartos C, Ambrus R, Szabó-Révész P, Katona G.

J Pharm Sci. 2019 Aug;108(8):2552-2560. doi: 10.1016/j.xphs.2019.03.005. Epub 2019 Mar 13.

PMID:
30878514
8.

Cocrystal Formation of Betulinic Acid and Ascorbic Acid: Synthesis, Physico-Chemical Assessment, Antioxidant, and Antiproliferative Activity.

Nicolov M, Ghiulai RM, Voicu M, Mioc M, Duse AO, Roman R, Ambrus R, Zupko I, Moaca EA, Coricovac DE, Farcas C, Racoviceanu RM, Danciu C, Dehelean CA, Soica C.

Front Chem. 2019 Feb 21;7:92. doi: 10.3389/fchem.2019.00092. eCollection 2019.

9.

Electrospun nanofiber-based niflumic acid capsules with superior physicochemical properties.

Radacsi N, Giapis KP, Ovari G, Szabó-Révész P, Ambrus R.

J Pharm Biomed Anal. 2019 Mar 20;166:371-378. doi: 10.1016/j.jpba.2019.01.037. Epub 2019 Jan 23.

PMID:
30711806
10.

Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery.

Chvatal A, Ambrus R, Party P, Katona G, Jójárt-Laczkovich O, Szabó-Révész P, Fattal E, Tsapis N.

Int J Pharm. 2019 Mar 25;559:68-75. doi: 10.1016/j.ijpharm.2019.01.034. Epub 2019 Jan 21.

PMID:
30677482
11.

Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach.

Bartos C, Pallagi E, Szabó-Révész P, Ambrus R, Katona G, Kiss T, Rahimi M, Csóka I.

Eur J Pharm Sci. 2018 Oct 15;123:475-483. doi: 10.1016/j.ejps.2018.07.061. Epub 2018 Aug 1.

PMID:
30076956
12.

Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties.

Ambrus R, Benke E, Farkas Á, Balásházy I, Szabó-Révész P.

Eur J Pharm Sci. 2018 Oct 15;123:20-27. doi: 10.1016/j.ejps.2018.07.030. Epub 2018 Jul 17.

PMID:
30016647
13.

Optimization of a combined wet milling process in order to produce poly(vinyl alcohol) stabilized nanosuspension.

Bartos C, Jójárt-Laczkovich O, Katona G, Budai-Szűcs M, Ambrus R, Bocsik A, Gróf I, Deli MA, Szabó-Révész P.

Drug Des Devel Ther. 2018 May 31;12:1567-1580. doi: 10.2147/DDDT.S159965. eCollection 2018.

14.

Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation.

Alshweiat A, Katona G, Csóka I, Ambrus R.

Eur J Pharm Sci. 2018 Sep 15;122:94-104. doi: 10.1016/j.ejps.2018.06.010. Epub 2018 Jun 14.

PMID:
29908301
15.

Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems.

Bartos C, Ambrus R, Kovács A, Gáspár R, Sztojkov-Ivanov A, Márki Á, Janáky T, Tömösi F, Kecskeméti G, Szabó-Révész P.

Molecules. 2018 Mar 28;23(4). pii: E784. doi: 10.3390/molecules23040784.

16.

Rutin and Its Cyclodextrin Inclusion Complexes: Physico-chemical Evaluation and in vitro Activity on B164A5 Murine Melanoma Cell Line.

Corina D, Florina B, Iulia P, Cristina D, Rita A, Alexandra P, Virgil P, Hancianu M, Daliana M, Codruta S.

Curr Pharm Biotechnol. 2017;18(13):1067-1077. doi: 10.2174/1389201019666180209165523.

PMID:
29437003
17.

Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.

Karimi K, Katona G, Csóka I, Ambrus R.

J Pharm Biomed Anal. 2018 Jan 30;148:73-79. doi: 10.1016/j.jpba.2017.09.019. Epub 2017 Sep 22.

PMID:
28965047
18.

Preliminary study of nanonized lamotrigine containing products for nasal powder formulation.

Gieszinger P, Csóka I, Pallagi E, Katona G, Jójárt-Laczkovich O, Szabó-Révész P, Ambrus R.

Drug Des Devel Ther. 2017 Aug 23;11:2453-2466. doi: 10.2147/DDDT.S138559. eCollection 2017.

19.

Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.

Iurian S, Bogdan C, Tomuță I, Szabó-Révész P, Chvatal A, Leucuța SE, Moldovan M, Ambrus R.

Eur J Pharm Sci. 2017 Jun 15;104:356-365. doi: 10.1016/j.ejps.2017.04.011. Epub 2017 Apr 20.

PMID:
28435075
20.

Aerodynamic properties and in silico deposition of meloxicam potassium incorporated in a carrier-free DPI pulmonary system.

Chvatal A, Farkas Á, Balásházy I, Szabó-Révész P, Ambrus R.

Int J Pharm. 2017 Mar 30;520(1-2):70-78. doi: 10.1016/j.ijpharm.2017.01.070. Epub 2017 Feb 1.

PMID:
28161667

Supplemental Content

Loading ...
Support Center